美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ayala Pharmaceuticals, Inc.

0.0333

+0.0000

成交量：62.00

成交額：2.10

市值：141.84萬

市盈率：0.00

高：0.0333

開：0.0333

低：0.0333

收：0.0333

資料載入中...

總覽公司新聞公告

美國OTC市場Advaxis, Inc.盤中異動股價大漲232.07%報0.105美元

美國OTC市場Advaxis, Inc.盤中異動大幅下挫71.41%報0.030美元

美國OTC市場Advaxis, Inc.盤中異動股價大漲250.33%

美國OTC市場Advaxis, Inc.盤中異動股價大漲5.56%報0.029美元

美國OTC市場Advaxis, Inc.盤中異動下午盤股價大漲5.26%報0.030美元

美國OTC市場Advaxis, Inc.盤中異動股價大漲5.56%

美國OTC市場Advaxis, Inc.盤中異動早盤急速拉昇1561.11%報0.449美元

美國OTC市場Advaxis, Inc.股價重挫10.00% 市值跌11.5萬美元

美國OTC市場Advaxis, Inc.盤中異動下午盤股價大漲148.15%

美國OTC市場Advaxis, Inc.股價拉昇289.26% 市值漲1295.02萬美元

美國OTC市場Advaxis, Inc.盤中異動股價大漲289.26%

美國OTC市場Advaxis, Inc.盤中異動早盤急速下挫74.31%報0.027美元

美國OTC市場Advaxis, Inc.股價上漲289.26% 市值漲1295.02萬美元

美國OTC市場Advaxis, Inc.盤中異動早盤快速下跌74.31%報0.027美元

美國OTC市場Advaxis, Inc.盤中異動早盤大幅拉昇289.26%報0.105美元

美國OTC市場Advaxis, Inc.盤中異動股價大漲250.33%

美國OTC市場Advaxis, Inc.盤中異動臨近收盤股價大漲11.11%

美國OTC市場Advaxis, Inc.股價重挫74.31% 市值跌85.46萬美元

美國OTC市場Advaxis, Inc.盤中異動早盤快速拉昇288.54%報0.105美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADXS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADXS\",,,,,undefined,":{"symbol":"ADXS","market":"US","secType":"STK","nameCN":"Ayala Pharmaceuticals, Inc.","latestPrice":0.0333,"timestamp":1746025604756,"preClose":0.0333,"halted":0,"volume":62,"delay":15,"floatShares":18100900,"shares":42593900,"eps":-7.986625,"marketStatus":"交易中","change":0,"latestTime":"04-30 11:06:44 EDT 延時","open":0.0333,"high":0.0333,"low":0.0333,"amount":2.1003,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-7.986625,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"exchange":"EXPERT","adjPreClose":0.0333,"volumeRatio":0.01499},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADXS\",,,,,undefined,":{"symbol":"ADXS","floatShares":18100900,"roa":"-181.05%","roe":"-392.03%","lyrEps":-7.986625,"volumeRatio":0.01499,"shares":42593900,"dividePrice":0,"high":0.0333,"amplitude":0,"preClose":0.0333,"low":0.0333,"week52Low":0.0012,"pbRate":"-0.06","psRate":"109.11","week52High":0.777,"institutionHeld":0,"latestPrice":0.0333,"eps":-7.986625,"divideRate":0,"volume":62,"delay":15,"ttmEps":-7.986625,"open":0.0333,"prevYearClose":0.027,"prevWeekClose":0.11,"prevMonthClose":0.045,"prevQuarterClose":0.045,"fiveDayClose":0.1051,"twentyDayClose":0.03,"sixtyDayClose":0.0285},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADXS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529768299","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大漲232.07%報0.105美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529768299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529768299?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 22:00","pubTimestamp":1745416801,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时00分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨232.07%。截至发稿，该股报0.105美元/股，成交量150股，换手率0.00%，振幅0.00%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423220002a6c54475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423220002a6c54475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2514886983","title":"美國OTC市場Advaxis, Inc.盤中異動 大幅下挫71.41%報0.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886983?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 02:39","pubTimestamp":1740595140,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时39分，美国OTC市场Advaxis, Inc.股票出现异动，股价大幅下挫71.41%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023901a2552f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023901a2552f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2513999262","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大漲250.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513999262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513999262?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 22:46","pubTimestamp":1740149166,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时46分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速拉升250.33%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224606a24eb406&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224606a24eb406&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2507229106","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大漲5.56%報0.029美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507229106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507229106?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 23:17","pubTimestamp":1738250264,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时17分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速拉升5.56%。截至发稿，该股报0.029美元/股，成交量164股，换手率0.00%，振幅0.00%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231744961442ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231744961442ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2507765026","title":"美國OTC市場Advaxis, Inc.盤中異動 下午盤股價大漲5.26%報0.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507765026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507765026?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 04:14","pubTimestamp":1738181642,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日04时14分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨5.26%。截至发稿，该股报0.030美元/股，成交量403股，换手率0.00%，振幅1087.72%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130041402abbc950a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130041402abbc950a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2505025510","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大漲5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505025510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505025510?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 04:23","pubTimestamp":1737663781,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时23分，美国OTC市场Advaxis, Inc.股票出现波动，股价快速上涨5.56%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042301a22d4de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042301a22d4de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2505270196","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤急速拉昇1561.11%報0.449美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505270196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505270196?lang=zh_tw&edition=fundamental","pubTime":"2025-01-21 23:42","pubTimestamp":1737474120,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时42分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速拉升1561.11%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121234201a22a66f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121234201a22a66f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2502575890","title":"美國OTC市場Advaxis, Inc.股價重挫10.00% 市值跌11.5萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502575890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502575890?lang=zh_tw&edition=fundamental","pubTime":"2025-01-11 01:32","pubTimestamp":1736530321,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日01时32分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速下挫10.00%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为1.95%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111013202aba62b14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111013202aba62b14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2500647710","title":"美國OTC市場Advaxis, Inc.盤中異動 下午盤股價大漲148.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500647710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500647710?lang=zh_tw&edition=fundamental","pubTime":"2025-01-01 04:41","pubTimestamp":1735677660,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时41分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速上涨148.15%。截至发稿，该股报0.067美元/股，成交量1683股，换手率0.00%，振幅148.15%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101044100a210cf4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101044100a210cf4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2493766908","title":"美國OTC市場Advaxis, Inc.股價拉昇289.26% 市值漲1295.02萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493766908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493766908?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 22:46","pubTimestamp":1734965187,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅拉升289.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223224627a2051128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223224627a2051128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2490382815","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大漲289.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490382815","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490382815?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 22:46","pubTimestamp":1734014764,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨289.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224604a1e9583e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224604a1e9583e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2488076197","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤急速下挫74.31%報0.027美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488076197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488076197?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 22:48","pubTimestamp":1733323685,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时48分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速下跌74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204224805a26c671d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204224805a26c671d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2488677491","title":"美國OTC市場Advaxis, Inc.股價上漲289.26% 市值漲1295.02萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488677491?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 22:46","pubTimestamp":1733150762,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时46分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速上涨289.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224602abf008da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224602abf008da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","ADXSD","BK4139"],"gpt_icon":0},{"id":"2484607148","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤快速下跌74.31%報0.027美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484607148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484607148?lang=zh_tw&edition=fundamental","pubTime":"2024-11-20 22:45","pubTimestamp":1732113944,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时45分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速下跌74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224544971a7b1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224544971a7b1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2484679084","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤大幅拉昇289.26%報0.105美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484679084?lang=zh_tw&edition=fundamental","pubTime":"2024-11-18 22:46","pubTimestamp":1731941165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨289.26%。截至发稿，该股报0.105美元/股，成交量1780股，换手率0.00%，振幅289.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822460595be48c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822460595be48c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2483022798","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大漲250.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483022798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483022798?lang=zh_tw&edition=fundamental","pubTime":"2024-11-14 22:46","pubTimestamp":1731595563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨250.33%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422460395be2d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422460395be2d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2483054246","title":"美國OTC市場Advaxis, Inc.盤中異動 臨近收盤股價大漲11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483054246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483054246?lang=zh_tw&edition=fundamental","pubTime":"2024-11-13 04:58","pubTimestamp":1731445081,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时58分，美国OTC市场Advaxis, Inc.股票出现异动，股价大幅上涨11.11%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304580295be1c9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304580295be1c9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2482734838","title":"美國OTC市場Advaxis, Inc.股價重挫74.31% 市值跌85.46萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482734838","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482734838?lang=zh_tw&edition=fundamental","pubTime":"2024-11-11 23:52","pubTimestamp":1731340321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时52分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速下跌74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123520195be11b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123520195be11b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2481102603","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤快速拉昇288.54%報0.105美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481102603?lang=zh_tw&edition=fundamental","pubTime":"2024-11-08 22:46","pubTimestamp":1731077195,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨288.54%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463595bdefee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463595bdefee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-09-12","symbol":"ADXS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1662955200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-06-06","symbol":"ADXS","defaultRemindTime":1654522200000,"type":"split","dateTimestamp":1654488000000,"forFactor":80,"toFactor":1,"ratio":80},{"market":"US","date":"2021-09-10","symbol":"ADXS","fiscalQuarterEnding":"2021/07","expectedEps":-0.04,"name":null,"time":"盤前","type":"earning","dateTimestamp":1631246400000,"reportTimeType":"pre","actualEps":-0.02},{"market":"US","date":"2021-06-14","symbol":"ADXS","fiscalQuarterEnding":"2021/04","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1623643200000,"reportTimeType":"","actualEps":-0.04},{"market":"US","date":"2021-03-16","symbol":"ADXS","fiscalQuarterEnding":"2021/01","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1615867200000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADXS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADXS","date":"2021-12-21","current":-2.2851,"percent":0.38764,"low":-10.115853,"twenty":-3.753596,"median":-1.301833,"eighty":-0.326835,"high":-0.062533,"avg":-2.182396,"sd":2.116831,"marketCap":43138111},"quantilePoints":[{"date":"2020-05-01","current":-1.050254,"twenty":-13.995304,"median":-3.117643,"eighty":-0.329769,"marketCap":39159765},{"date":"2020-05-08","current":-1.1779,"twenty":-13.731134,"median":-3.066489,"eighty":-0.329769,"marketCap":43919183},{"date":"2020-05-15","current":-1.186141,"twenty":-13.290121,"median":-3.011788,"eighty":-0.329769,"marketCap":44226436},{"date":"2020-05-22","current":-1.145746,"twenty":-12.871546,"median":-2.887082,"eighty":-0.329769,"marketCap":42720291},{"date":"2020-05-29","current":-1.108422,"twenty":-12.40428,"median":-2.877199,"eighty":-0.329769,"marketCap":41328613},{"date":"2020-06-05","current":-1.254165,"twenty":-11.759186,"median":-2.776245,"eighty":-0.329769,"marketCap":46762784},{"date":"2020-06-12","current":-1.187295,"twenty":-11.514976,"median":-2.657972,"eighty":-0.329769,"marketCap":40636359},{"date":"2020-06-19","current":-1.143194,"twenty":-11.377855,"median":-2.536478,"eighty":-0.329769,"marketCap":39126974},{"date":"2020-06-26","current":-1.017013,"twenty":-11.241347,"median":-2.478532,"eighty":-0.329769,"marketCap":34808282},{"date":"2020-07-02","current":-0.998293,"twenty":-11.100588,"median":-2.391356,"eighty":-0.329769,"marketCap":34167563},{"date":"2020-07-10","current":-1.024213,"twenty":-11.011304,"median":-2.14528,"eighty":-0.329769,"marketCap":35054713},{"date":"2020-07-17","current":-1.010353,"twenty":-10.829218,"median":-2.031706,"eighty":-0.329769,"marketCap":34580334},{"date":"2020-07-24","current":-1.076414,"twenty":-10.648722,"median":-2.019673,"eighty":-0.329769,"marketCap":36841332},{"date":"2020-07-31","current":-1.044553,"twenty":-10.472726,"median":-2.006468,"eighty":-0.329769,"marketCap":35750878},{"date":"2020-08-07","current":-0.990013,"twenty":-10.252975,"median":-1.988017,"eighty":-0.329769,"marketCap":33884169},{"date":"2020-08-14","current":-0.941592,"twenty":-10.153589,"median":-1.931036,"eighty":-0.329769,"marketCap":32226925},{"date":"2020-08-21","current":-0.831971,"twenty":-10.022739,"median":-1.9072,"eighty":-0.329769,"marketCap":28475023},{"date":"2020-08-28","current":-0.956532,"twenty":-9.885586,"median":-1.886717,"eighty":-0.329769,"marketCap":32738268},{"date":"2020-09-04","current":-0.79201,"twenty":-9.778397,"median":-1.817073,"eighty":-0.329769,"marketCap":27107335},{"date":"2020-09-11","current":-0.965877,"twenty":-9.712432,"median":-1.801162,"eighty":-0.329769,"marketCap":29166579},{"date":"2020-09-18","current":-0.975965,"twenty":-9.651309,"median":-1.701097,"eighty":-0.329769,"marketCap":29471225},{"date":"2020-09-25","current":-0.851393,"twenty":-9.608549,"median":-1.667742,"eighty":-0.329769,"marketCap":25709505},{"date":"2020-10-02","current":-0.897888,"twenty":-9.553343,"median":-1.645506,"eighty":-0.329769,"marketCap":27113527},{"date":"2020-10-09","current":-0.899423,"twenty":-9.507604,"median":-1.623269,"eighty":-0.329769,"marketCap":27159886},{"date":"2020-10-16","current":-0.889554,"twenty":-9.480566,"median":-1.612151,"eighty":-0.329769,"marketCap":26861863},{"date":"2020-10-23","current":-1.116987,"twenty":-9.439867,"median":-1.578796,"eighty":-0.329769,"marketCap":33729651},{"date":"2020-10-30","current":-0.741295,"twenty":-9.352805,"median":-1.54319,"eighty":-0.329769,"marketCap":22384885},{"date":"2020-11-06","current":-0.811477,"twenty":-9.319791,"median":-1.499753,"eighty":-0.329769,"marketCap":24504165},{"date":"2020-11-13","current":-0.877272,"twenty":-9.287317,"median":-1.441226,"eighty":-0.329769,"marketCap":26490989},{"date":"2020-11-20","current":-0.843278,"twenty":-9.241007,"median":-1.426594,"eighty":-0.329769,"marketCap":25464463},{"date":"2020-11-27","current":-0.87766,"twenty":-9.219963,"median":-1.390015,"eighty":-0.329769,"marketCap":26502697},{"date":"2020-12-04","current":-1.09097,"twenty":-9.198559,"median":-1.368067,"eighty":-0.329769,"marketCap":32944006},{"date":"2020-12-11","current":-1.0653,"twenty":-9.18485,"median":-1.34612,"eighty":-0.329769,"marketCap":32168853},{"date":"2020-12-18","current":-1.004975,"twenty":-9.08076,"median":-1.331488,"eighty":-0.329769,"marketCap":30347244},{"date":"2020-12-24","current":-1.235363,"twenty":-9.018181,"median":-1.322944,"eighty":-0.329769,"marketCap":37304243},{"date":"2020-12-31","current":-1.178212,"twenty":-8.979116,"median":-1.316856,"eighty":-0.329769,"marketCap":35578455},{"date":"2021-01-08","current":-1.418468,"twenty":-8.955215,"median":-1.30887,"eighty":-0.328243,"marketCap":42833487},{"date":"2021-01-15","current":-1.955893,"twenty":-8.898511,"median":-1.30887,"eighty":-0.328243,"marketCap":59062093},{"date":"2021-01-22","current":-2.430254,"twenty":-8.753535,"median":-1.30887,"eighty":-0.328243,"marketCap":73386369},{"date":"2021-01-29","current":-2.953169,"twenty":-8.618443,"median":-1.30887,"eighty":-0.328243,"marketCap":78167435},{"date":"2021-02-05","current":-4.026395,"twenty":-8.567176,"median":-1.302224,"eighty":-0.327449,"marketCap":106574652},{"date":"2021-02-12","current":-4.674476,"twenty":-8.43427,"median":-1.302224,"eighty":-0.327449,"marketCap":123728715},{"date":"2021-02-19","current":-5.076354,"twenty":-8.342184,"median":-1.302224,"eighty":-0.327449,"marketCap":134366025},{"date":"2021-02-26","current":-3.735351,"twenty":-8.130804,"median":-1.302224,"eighty":-0.327449,"marketCap":98871000},{"date":"2021-03-05","current":-2.983627,"twenty":-7.523871,"median":-1.302029,"eighty":-0.327142,"marketCap":78973631},{"date":"2021-03-12","current":-3.473919,"twenty":-5.928978,"median":-1.302029,"eighty":-0.327142,"marketCap":91951150},{"date":"2021-03-19","current":-4.431937,"twenty":-5.796985,"median":-1.301833,"eighty":-0.326835,"marketCap":100113027},{"date":"2021-03-26","current":-3.977108,"twenty":-5.710324,"median":-1.302029,"eighty":-0.327142,"marketCap":89838898},{"date":"2021-04-01","current":-3.893547,"twenty":-5.670327,"median":-1.302029,"eighty":-0.327142,"marketCap":87951325},{"date":"2021-04-09","current":-3.754464,"twenty":-5.550334,"median":-1.301833,"eighty":-0.326835,"marketCap":84809589},{"date":"2021-04-16","current":-2.766952,"twenty":-5.506336,"median":-1.301833,"eighty":-0.326835,"marketCap":62502681},{"date":"2021-04-23","current":-2.919356,"twenty":-5.457006,"median":-1.301833,"eighty":-0.326835,"marketCap":65945342},{"date":"2021-04-30","current":-3.009136,"twenty":-5.399676,"median":-1.302029,"eighty":-0.327142,"marketCap":67973368},{"date":"2021-05-07","current":-2.55291,"twenty":-5.377011,"median":-1.302029,"eighty":-0.327142,"marketCap":57667684},{"date":"2021-05-14","current":-2.271968,"twenty":-5.330347,"median":-1.302029,"eighty":-0.327142,"marketCap":51321479},{"date":"2021-05-21","current":-3.346877,"twenty":-5.301015,"median":-1.302224,"eighty":-0.327449,"marketCap":75602609},{"date":"2021-05-28","current":-3.001807,"twenty":-5.239686,"median":-1.302224,"eighty":-0.327449,"marketCap":67807815},{"date":"2021-06-04","current":-3.175869,"twenty":-5.194355,"median":-1.302224,"eighty":-0.327449,"marketCap":71739702},{"date":"2021-06-11","current":-3.202742,"twenty":-5.101067,"median":-1.302224,"eighty":-0.327449,"marketCap":72346731},{"date":"2021-06-18","current":-3.338925,"twenty":-4.858321,"median":-1.302224,"eighty":-0.327449,"marketCap":71362844},{"date":"2021-06-25","current":-3.372996,"twenty":-4.685103,"median":-1.302224,"eighty":-0.327449,"marketCap":72091037},{"date":"2021-07-02","current":-3.255111,"twenty":-4.566651,"median":-1.302224,"eighty":-0.327449,"marketCap":69571491},{"date":"2021-07-09","current":-3.366863,"twenty":-4.498845,"median":-1.302224,"eighty":-0.327449,"marketCap":71959962},{"date":"2021-07-16","current":-3.060908,"twenty":-4.466254,"median":-1.302224,"eighty":-0.327449,"marketCap":65420795},{"date":"2021-07-23","current":-2.957334,"twenty":-4.429881,"median":-1.302224,"eighty":-0.327449,"marketCap":63207091},{"date":"2021-07-30","current":-2.807423,"twenty":-4.397371,"median":-1.302224,"eighty":-0.327449,"marketCap":60003045},{"date":"2021-08-06","current":-2.971643,"twenty":-4.319203,"median":-1.302224,"eighty":-0.327449,"marketCap":63512931},{"date":"2021-08-13","current":-2.927351,"twenty":-4.272365,"median":-1.302224,"eighty":-0.327449,"marketCap":62566281},{"date":"2021-08-20","current":-2.634344,"twenty":-4.24616,"median":-1.302224,"eighty":-0.327449,"marketCap":56303828},{"date":"2021-08-27","current":-3.194465,"twenty":-4.207084,"median":-1.301833,"eighty":-0.326835,"marketCap":68275309},{"date":"2021-09-03","current":-3.159032,"twenty":-4.144564,"median":-1.301833,"eighty":-0.326835,"marketCap":67517989},{"date":"2021-09-10","current":-3.190377,"twenty":-4.12073,"median":-1.301833,"eighty":-0.326835,"marketCap":68187926},{"date":"2021-09-17","current":-4.037112,"twenty":-4.102884,"median":-1.301833,"eighty":-0.326835,"marketCap":76212605},{"date":"2021-09-24","current":-4.087258,"twenty":-4.062507,"median":-1.301833,"eighty":-0.326835,"marketCap":77159255},{"date":"2021-10-01","current":-4.023226,"twenty":-4.026063,"median":-1.301833,"eighty":-0.326835,"marketCap":75950456},{"date":"2021-10-08","current":-3.625918,"twenty":-3.978738,"median":-1.301833,"eighty":-0.326835,"marketCap":68450075},{"date":"2021-10-15","current":-3.749353,"twenty":-3.966062,"median":-1.301833,"eighty":-0.326835,"marketCap":70780291},{"date":"2021-10-22","current":-3.885132,"twenty":-3.950462,"median":-1.301833,"eighty":-0.326835,"marketCap":73343527},{"date":"2021-10-29","current":-3.735467,"twenty":-3.933481,"median":-1.301833,"eighty":-0.326835,"marketCap":70518141},{"date":"2021-11-05","current":-3.854273,"twenty":-3.918915,"median":-1.301833,"eighty":-0.326835,"marketCap":72760974},{"date":"2021-11-12","current":-3.425335,"twenty":-3.905807,"median":-1.301833,"eighty":-0.326835,"marketCap":64663475},{"date":"2021-11-19","current":-2.909992,"twenty":-3.888494,"median":-1.301833,"eighty":-0.326835,"marketCap":54934826},{"date":"2021-11-26","current":-2.967852,"twenty":-3.868828,"median":-1.301833,"eighty":-0.326835,"marketCap":56027115},{"date":"2021-12-03","current":-2.655406,"twenty":-3.846404,"median":-1.301833,"eighty":-0.326835,"marketCap":50128757},{"date":"2021-12-10","current":-2.683179,"twenty":-3.806425,"median":-1.301833,"eighty":-0.326835,"marketCap":50653056},{"date":"2021-12-17","current":-2.391563,"twenty":-3.767552,"median":-1.301833,"eighty":-0.326835,"marketCap":45147922},{"date":"2021-12-21","current":-2.2851,"twenty":-3.753596,"median":-1.301833,"eighty":-0.326835,"marketCap":43138111}],"updateTime":1746010561360}}}